PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Molecular Cell Biology-Genetics, Faculty of Basic Sciences and Advanced Technologies in biology, University of Science and Culture, Tehran, Iran.\', \'Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.\', \'Chronic Respiratory Diseases Research Center (CRDRC), National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.\', \'Experimental Cancer Medicine, Institution for Laboratory Medicine, Karolinska Institutet, Huddinge, Sweden.\', \'Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran. masvos@Royaninstitute.org.\', \'Experimental Cancer Medicine, Institution for Laboratory Medicine, Karolinska Institutet, Huddinge, Sweden. masvos@Royaninstitute.org.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s11033-021-07071-9
?:hasPublicationType
?:journal
  • Molecular biology reports
is ?:pmid of
?:pmid
?:pmid
  • 35028855
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.721
?:rankingScore_hIndex
  • 56
is ?:relation_isRelatedTo_publication of
?:title
  • Mini review ATF4 and GRP78 as novel molecular targets in ER-Stress modulation for critical COVID-19 patients.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all